Citius Oncology, Inc.

CTOR ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $100.9M

Liabilities Breakdown FY2025

Total Liabilities: $56.1M